Evaluation of efficacy of gokshuradi gutika in diabetic kidney disease-an open clinical trial

Evaluation of efficacy of gokshuradi gutika in incipient diabetic nephropathy (microalbuminuria) an open clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/015042

Enrollment

Registered

2018-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stable type 2 DM microalbuinuria between 30 to 300 mcg/24 hours 40-80 years of age of either sex Health Condition 2: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: Gokshuradi gutika: 500 mg BD for 60 days Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: Stable type 2 Diabetes mellitus Microalbuminuria 30-300 micrograms/24 hours 40-80 years of age of an either sex

Exclusion criteria

Exclusion criteria: The patients having any other complications of diabetes such as cardiomyopathy, hyperkalemia and other uremic symptoms. Patients having other systemic disorders which interfere with the course of treatment. The patient who are febrile, having recurrent UTI, marked hypertension. Pregnant and lactation female subjects The patient who are on ACE inhibitors and ARB medicines.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of gokshuradi gutika on incipient diabetic nephropathy (micro albuminuriaTimepoint: On the first visit Day 0 On third visit Day 60	—

Secondary

Measure	Time frame
NOT APPLICABLETimepoint: NOT APPLICABLE	—

Countries

India

Contacts

Public ContactDr Kashavva Hiremath

KAHERS shri B M K ayurveda mahavidyalaya and ayurveda hospital

drkvhiremath@gmail.com9448945687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026